New outpatient medication copayment 2026: what changes for patients and pharmacies

Key data

Patients receiving medication financed by the National Health System in outpatient care are already subject to the new copayment conditions as of May 13, 2026. Royal Decree-Law 11/2026, approved by the Government as an urgent measure, has received parliamentary support from the Congress of Deputies through Resolution of May 28, 2026, published in the BOE on May 30, 2026.

The validation, under Article 86.2 of the Constitution, grants full legal validity to the changes introduced. This means that pharmacies and pharmaceutical service managers cannot wait: operational adaptation is mandatory from the date of entry into force.

What does this regulation establish?

RDL 11/2026 modifies the economic contribution of users and their beneficiaries in outpatient pharmaceutical care, that is, medications dispensed in pharmacies with SNS prescriptions outside the hospital environment.

The three axes of change are:

• Contribution brackets by income: The percentages or amounts that each user pays based on their income level are modified. The system maintains the structure of income brackets, but with new conditions established in the decree.
• Exempt groups: The groups of population that are exempt from contribution or that enjoy special copayment conditions are reviewed.
• Maximum spending limits: The caps on monthly or annual user contributions that protect users with higher pharmaceutical consumption are updated.

The regulation affects exclusively outpatient pharmaceutical care, not hospital dispensing, which has a differentiated regime.

Economic and operational impact

For pharmacies, the impact is immediate and operational in nature: billing and dispensing systems must reflect the new contribution conditions as of May 13, 2026. Any mismatch in applying the correct copayment generates billing problems with the SNS and potential user claims.

For pharmaceutical service managers (pharmacy associations, regional health services, mutual societies), adaptation involves updating information systems, electronic prescription modules and settlement processes with regional communities.

For SNS patients and beneficiaries, the change may result in a variation in the amount they pay at each dispensation, depending on the income bracket they belong to and whether their group is affected by the new exemption conditions or the new maximum spending limits.

Who does it affect?

• Patients with medication financed by the SNS in outpatient care: Any person who withdraws medications with a prescription at a pharmacy and whose cost is fully or partially financed by the public system.
• SNS beneficiaries: People included in public health coverage, including dependents of policyholders.
• Pharmacies: Required to apply the new contribution conditions at the time of dispensing and to adapt their SNS billing systems.
• Pharmaceutical service managers: Regional health services, official pharmacy associations and management entities of civil servant mutual societies that manage pharmaceutical care.
• Civil servant mutual societies (MUFACE, MUGEJU, ISFAS): To the extent that their copayment systems are referenced to the general SNS regime.

Practical example

A pharmacy in Madrid that manages dozens of SNS prescriptions daily must, as of May 13, 2026, apply the new contribution brackets in each dispensation. If a patient belongs to a group that has become exempt under the new regime, the pharmacy cannot charge them the previous contribution: it must apply the exemption immediately or face claims and possible adjustments in settlement with the regional health service.

Similarly, a patient with chronic treatment who previously reached the maximum monthly spending limit in the second week of the month could see that cap modified, which directly affects the amount they pay for the rest of the month. This type of change requires that the electronic prescription system be updated to correctly apply the current limit.

What should companies do now?

1. Pharmacies: update billing and dispensing systems to reflect the new contribution brackets, exempt groups and maximum spending limits established in RDL 11/2026. The regulation is already in force as of May 13, 2026.
2. Pharmaceutical service managers: review electronic prescription modules and settlement processes with regional communities to ensure that the contribution amounts applied are correct under the new regulation.
3. Civil servant mutual societies: verify whether their copayment regime is referenced to the general SNS system and, if so, apply the same updates to brackets, exemptions and limits.
4. All affected parties: consult the full text of RDL 11/2026 in the BOE to know the exact brackets, exempt groups and specific maximum spending limits established by the regulation, as these data determine the practical application of copayment.
5. Communicate to patients any change in their contribution clearly, especially to those with chronic or high-cost treatments, to avoid claims and ensure proper management of dispensations.

Official source

Consult complete regulation in official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-11625